source
- Verastem reports encouraging early data for KRAS G12D inhibitor in pancreatic cancerVerastem Oncology disclosed early clinical results for its KRAS G12D inhibitor, which is being evaluated in more than 200 patients with advanced solid tumors, including metastatic pancreatic ductal…
- Advocates race to shape rules for AI sandboxes in health careThe STAT Health Tech newsletter notes that AI sandboxes are becoming a popular mechanism for testing health‑care artificial intelligence under controlled conditions. A broad coalition of industry…